Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk

Carcinogenesis

Volumn 30, Issue 5, 2009, Pages 763-768

  Michiels, Stefan ^a   Laplanche, Agnès ^a   Boulet, Thomas ^a   Dessen, Philippe ^b   Guillonneau, Bertrand ^c   Méjean, Arnaud ^d   Desgrandchamps, François ^e   Lathrop, Mark ^f   Sarasin, Alain ^b   Benhamou, Simone ^b,g  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CNRS   (France)

^c INSTITUT MUTUALISTE MONTSOURIS   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^g FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA REPAIR PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; GENE PRODUCT; NUCLEIC ACID BINDING PROTEIN; PROTEIN POLB; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA REPAIR; DNA SYNTHESIS; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC STABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CELL CYCLE; DNA POLYMERASE BETA; DNA REPAIR; DNA REPLICATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PARIS; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 65549086166     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp046     Document Type: Article

References (40)

1. Stewart,B.W. et al. (2003) World Cancer Report. International Agency for Research on Cancer, IARC Press, Lyon.
2. Hoeijmakers,J.H. (2001) Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-374.
3. Bassing,C.H. et al. (2004) The cellular response to general and programmed DNA double strand breaks. DNA Repair, 3, 781-796.
4. Packer,B.R. et al. (2006) SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res., 34 617-621.
5. Thorisson,G.A. et al. (2005) The International HapMap Project Web site. Genome Res., 15, 1591-1593.
6. Palli,D. et al. (2001) DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int. J. Cancer, 94, 121-127.
7. Hou,S.M. et al. (2002) The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis, 23, 599-603.
8. Matullo,G. et al. (2003) Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol. Biomarkers Prev., 12 674-677.
9. Spitz,M.R. et al. (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 61, 1354-1357.
10. Qiao,Y. et al. (2002) Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat. Res., 509, 165-174.
11. Benhamou,S. et al. (2005) ERCC2/XPD gene polymorphisms and lung cancer: A HuGE review. Am. J. Epidemiol., 161, 1-14.
12. Manuguerra,M. et al. (2006) XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: A HuGE review. Am. J. Epidemiol., 164, 297-302.
13. Stern,M.C. et al. (2002) XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 1004-1011.
14. Shen,M. et al. (2003) Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol. Biomarkers Prev., 12, 1234-1240.
15. Kelsey,K.T. et al. (2004) A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer. Cancer Epidemiol. Biomarkers Prev., 13, 1337-1341.
16. Sanyal,S. et al. (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis, 25, 729-734.
17. Schabath,M.B. et al. (2005) Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 14 878-884.
18. Andrew,A.S. et al. (2006) Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis, 27, 1030-1037.
19. Garcia-Closas,M. et al. (2006) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 536-542.
20. Figueroa,J.D. et al. (2007) Genetic variation in the base excision repair pathway and bladder cancer risk. Hum. Genet., 121, 233-242.
21. Figueroa,J.D. et al. (2007) Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis, 28, 1788-1793.
22. Matullo,G. et al. (2005) Polymorphisms/haplotypes in DNA repair genes and smoking: A bladder cancer case-control study. Cancer Epidemiol. Biomarkers Prev., 14, 2569-2578.
23. Matullo,G. et al. (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis, 27, 997-1007.
24. Sak,S.C. et al. (2006) Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 2537-2541.
25. Wu,X. et al. (2006) Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet., 78, 464-479.
26. Benhamou,S. et al. (2003) DNA adducts in normal bladder tissue and bladder cancer risk. Mutagenesis, 18, 445-448.
27. Michiels,S. et al. (2007) Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis, 28, 1731-1739.
28. Danoy,P. et al. (2008) Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers. Int. J. Cancer, 123, 457-463.
29. International Agency for Research on Cancer. (1986) Tobacco Smoking. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC Scientific Publications, Lyon, Vol. 38, pp. 55.
30. Benjamini,Y. et al. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B, 57, 289-300.
31. Schaid,D.J. et al. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.
32. Lake,S.L. et al. (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum. Hered., 55, 56-65.
33. Ott,J. et al. (2003) Set association analysis of SNP case-control and microarray data. J. Comput. Biol., 10, 569-574.
34. Breiman,L. et al. (1984) Classification and Regression Trees Chapman & Hall, New York.
35. Hung,R.J. et al. (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am. J. Epidemiol., 162, 925-942.
36. Han,S. et al. (2006) DNA repair gene XRCC3 polymorphisms and cancer risk: A meta-analysis of 48 case-control studies. Eur. J. Hum. Genet., 14, 1136-1144.
37. Thompson,T.E. et al. (2002) Splice variants but not mutations of DNA polymerase beta are common in bladder cancer. Cancer Res., 62, 3251-3256.
38. D'Andrea,A.D. et al. (2003) The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer, 3, 23-34.
39. Yang,Y.G. et al. (2005) The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. Carcinogenesis, 26, 1731-1740.
40. Kiemeney,L.A. et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet., 40, 1307-1312.